Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Antimicrobial Agents and Chemotherapy|September 8, 2016
Inhibition of Cytochrome P450 2B6 Activity by Voriconazole Profiled Using Efavirenz Disposition in Healthy VolunteersZeruesenay Desta, Ingrid F Metzger, Nancy Thong, et al.
Thrombosis Research|March 31, 2012
Protease activated receptor-1 (PAR-1) mediated platelet aggregation is dependent on clopidogrel responseRolf P Kreutz, Jeffrey A Breall, Yvonne Kreutz, et al.
British Journal of Pharmacology|July 31, 2014
Simulation with cells in vitro of tamoxifen treatment in premenopausal breast cancer patients with different CYP2D6 genotypesPhilipp Y Maximov, Russell E McDaniel, Daphne J Fernandes, et al.
Diabetes Research and Clinical Practice|June 1, 2016
Comparative risk of severe hypoglycemia among concomitant users of thiazolidinedione antidiabetic agents and antihyperlipidemicsCharles E Leonard, Xu Han, Warren B Bilker, et al.
Frontiers in Pharmacology|April 6, 2012
Whole genome amplification of DNA for genotyping pharmacogenetics candidate genesSantosh Philips, James M Rae, Steffi Oesterreich, et al.
Nature Reviews. Drug Discovery|July 1, 2008
Creating and evaluating genetic tests predictive of drug responseScott T Weiss, Howard L McLeod, David A Flockhart, et al.
Clinical Pharmacology : Advances and Applications|March 20, 2012
Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel responseRolf P Kreutz, Perry Nystrom, Yvonne Kreutz, et al.
Breast Cancer Research and Treatment|April 28, 2004
Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifenMichael D Johnson, Hong Zuo, Kyung-Hoon Lee, et al.
Pharmacogenomics|October 16, 2008
VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-AmericansNita A Limdi, T Mark Beasley, Michael R Crowley, et al.
Clinical Pharmacology : Advances and Applications|December 20, 2013
Cytochrome P450 3A4*22, PPAR-α, and ARNT polymorphisms and clopidogrel responseRolf P Kreutz, Janelle Owens, Yan Jin, et al.
Pageof 14